Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.

Amarzguioui M, Lundberg P, Cantin E, Hagstrom J, Behlke MA, Rossi JJ.

Nat Protoc. 2006;1(2):508-17.

PMID:
17406276
2.

Gene silencing mediated by small interfering RNAs in mammalian cells.

Scherr M, Morgan MA, Eder M.

Curr Med Chem. 2003 Feb;10(3):245-56. Review.

PMID:
12570711
3.

Targeted gene silencing by small interfering RNA-based knock-down technology.

Zhang J, Hua ZC.

Curr Pharm Biotechnol. 2004 Feb;5(1):1-7. Review.

PMID:
14965205
4.

Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.

Aigner A.

J Biotechnol. 2006 Jun 25;124(1):12-25. Epub 2006 Jan 18. Review.

PMID:
16413079
5.

The Argonautes.

Joshua-Tor L.

Cold Spring Harb Symp Quant Biol. 2006;71:67-72. Review.

PMID:
17381282
6.

RNA interference and human disease.

Cheng JC, Moore TB, Sakamoto KM.

Mol Genet Metab. 2003 Sep-Oct;80(1-2):121-8. Review.

PMID:
14567961
7.

RNA interference-based gene silencing in mice: the development of a novel therapeutical strategy.

Spänkuch B, Strebhardt K.

Curr Pharm Des. 2005;11(26):3405-19. Review.

PMID:
16250844
8.

The ins and outs of RNAi in mammalian cells.

Banan M, Puri N.

Curr Pharm Biotechnol. 2004 Oct;5(5):441-50. Review.

PMID:
15544492
9.

Targeted delivery systems of small interfering RNA by systemic administration.

Kawakami S, Hashida M.

Drug Metab Pharmacokinet. 2007 Jun;22(3):142-51. Review.

10.

Nonviral in vivo delivery of therapeutic small interfering RNAs.

Aigner A.

Curr Opin Mol Ther. 2007 Aug;9(4):345-52. Review.

PMID:
17694447
11.

siRNA--getting the message out.

Lee SH, Sinko PJ.

Eur J Pharm Sci. 2006 Apr;27(5):401-10. Epub 2006 Jan 25. Review.

PMID:
16442784
12.

Molecular design and delivery of siRNA.

Inoue A, Sawata SY, Taira K.

J Drug Target. 2006;14(7):448-55. Review.

PMID:
17062391
13.

RNase III enzymes and the initiation of gene silencing.

Carmell MA, Hannon GJ.

Nat Struct Mol Biol. 2004 Mar;11(3):214-8. Review.

PMID:
14983173
14.

Chemical modification of siRNA.

Chernolovskaya EL, Zenkova MA.

Curr Opin Mol Ther. 2010 Apr;12(2):158-67. Review.

PMID:
20373259
15.

Small interfering RNA for experimental cancer therapy.

Tong AW, Zhang YA, Nemunaitis J.

Curr Opin Mol Ther. 2005 Apr;7(2):114-24. Review.

PMID:
15844618
16.

Relationship between retroviral replication and RNA interference machineries.

Moelling K, Matskevich A, Jung JS.

Cold Spring Harb Symp Quant Biol. 2006;71:365-8. Review.

PMID:
17381318
17.

[Vector systems of RNA interference].

Kazachenko KIu, Avdonin PV.

Ontogenez. 2006 May-Jun;37(3):163-70. Review. Russian.

PMID:
16813217
18.

siRNA and isRNA: two edges of one sword.

Schlee M, Hornung V, Hartmann G.

Mol Ther. 2006 Oct;14(4):463-70. Epub 2006 Jul 31. Review.

19.

In silico selection of active siRNA.

Patzel V.

Drug Discov Today. 2007 Feb;12(3-4):139-48. Epub 2006 Dec 13. Review.

PMID:
17275734
20.

A non-covalent peptide-based strategy for siRNA delivery.

Crombez L, Charnet A, Morris MC, Aldrian-Herrada G, Heitz F, Divita G.

Biochem Soc Trans. 2007 Feb;35(Pt 1):44-6. Review.

PMID:
17233597

Supplemental Content

Support Center